Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.

<h4>Background</h4>Clinical evidence on the protective effects of a balanced diet, exercise, and medication adherence along with intensive glucose-lowering therapies on diabetes progression is lacking, and interventions that are most effective in slowing cardiorenal metabolic complicatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Marwan El-Deyarbi, Luai Ahmed, Jeffrey King, Zelal S Adi, Ahmed Al Juboori, Nirmin A Mansour, Huda Al Nuaimi, Rami Beiram, Salahdein Aburuz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327211
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839630423371546624
author Marwan El-Deyarbi
Luai Ahmed
Jeffrey King
Zelal S Adi
Ahmed Al Juboori
Nirmin A Mansour
Huda Al Nuaimi
Rami Beiram
Salahdein Aburuz
author_facet Marwan El-Deyarbi
Luai Ahmed
Jeffrey King
Zelal S Adi
Ahmed Al Juboori
Nirmin A Mansour
Huda Al Nuaimi
Rami Beiram
Salahdein Aburuz
author_sort Marwan El-Deyarbi
collection DOAJ
description <h4>Background</h4>Clinical evidence on the protective effects of a balanced diet, exercise, and medication adherence along with intensive glucose-lowering therapies on diabetes progression is lacking, and interventions that are most effective in slowing cardiorenal metabolic complications in patients with diabetes remain unelucidated.<h4>Objective</h4>To determine the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes attending ambulatory healthcare clinics.<h4>Methods</h4>We conducted a randomised controlled clinical trial at the Oud Al-Touba Clinic involving 192 participants with diabetes, who were blinded to the intervention and control groups, and followed up for 1 year. At the 3-, 6-, and 9-month visits, the intervention and control groups received multifactorial interventions and standard routine care, respectively. Glycated haemoglobin A1c (HbA1c) levels, estimated glomerular filtration rate (eGFR), blood pressure, electrolyte levels, and cardiovascular events were assessed at study completion.<h4>Results</h4>During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of -0.36% in HbA1c levels between the groups (95% CI: -0.54 - -0.19, P < 0.01). Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = -0.14, 95% CI: -0.27-0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m2, 95% CI: 1.27-6.58, P < 0.01) at study completion compared to those in the control group. Moreover, the percentage of participants in the intervention group who met the blood pressure target increased from 38.3% to 51.1%, accompanied with a decrease in serum electrolyte levels, compared to 34.7% to 36.7% in the control group at the end of the follow-up.<h4>Conclusions</h4>Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.<h4>Trial registration</h4>ClinicalTrials.gov NCT04942119.
format Article
id doaj-art-b9f55fbf6dc3493e844ffa2e89512ed6
institution Matheson Library
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-b9f55fbf6dc3493e844ffa2e89512ed62025-07-14T05:31:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032721110.1371/journal.pone.0327211Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.Marwan El-DeyarbiLuai AhmedJeffrey KingZelal S AdiAhmed Al JubooriNirmin A MansourHuda Al NuaimiRami BeiramSalahdein Aburuz<h4>Background</h4>Clinical evidence on the protective effects of a balanced diet, exercise, and medication adherence along with intensive glucose-lowering therapies on diabetes progression is lacking, and interventions that are most effective in slowing cardiorenal metabolic complications in patients with diabetes remain unelucidated.<h4>Objective</h4>To determine the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes attending ambulatory healthcare clinics.<h4>Methods</h4>We conducted a randomised controlled clinical trial at the Oud Al-Touba Clinic involving 192 participants with diabetes, who were blinded to the intervention and control groups, and followed up for 1 year. At the 3-, 6-, and 9-month visits, the intervention and control groups received multifactorial interventions and standard routine care, respectively. Glycated haemoglobin A1c (HbA1c) levels, estimated glomerular filtration rate (eGFR), blood pressure, electrolyte levels, and cardiovascular events were assessed at study completion.<h4>Results</h4>During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of -0.36% in HbA1c levels between the groups (95% CI: -0.54 - -0.19, P < 0.01). Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = -0.14, 95% CI: -0.27-0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m2, 95% CI: 1.27-6.58, P < 0.01) at study completion compared to those in the control group. Moreover, the percentage of participants in the intervention group who met the blood pressure target increased from 38.3% to 51.1%, accompanied with a decrease in serum electrolyte levels, compared to 34.7% to 36.7% in the control group at the end of the follow-up.<h4>Conclusions</h4>Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.<h4>Trial registration</h4>ClinicalTrials.gov NCT04942119.https://doi.org/10.1371/journal.pone.0327211
spellingShingle Marwan El-Deyarbi
Luai Ahmed
Jeffrey King
Zelal S Adi
Ahmed Al Juboori
Nirmin A Mansour
Huda Al Nuaimi
Rami Beiram
Salahdein Aburuz
Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
PLoS ONE
title Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
title_full Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
title_fullStr Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
title_full_unstemmed Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
title_short Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.
title_sort impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes a randomised controlled trial
url https://doi.org/10.1371/journal.pone.0327211
work_keys_str_mv AT marwaneldeyarbi impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT luaiahmed impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT jeffreyking impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT zelalsadi impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT ahmedaljuboori impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT nirminamansour impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT hudaalnuaimi impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT ramibeiram impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial
AT salahdeinaburuz impactofmultifactorialinterventionswithmedicationandlifestyleoptimizationonpatientswithtype2diabetesarandomisedcontrolledtrial